Yamashita Health Care Holdings,Inc. (TYO:9265)
Japan · Delayed Price · Currency is JPY 3,360.00
-140.00 (-4.00%)
Aug 6, 2026, 12:30 PM JST
TYO:9265 Income Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
| 64,149 | 64,486 | 61,555 | 58,195 | 55,145 | |
Revenue Growth | -0.52% | 4.76% | 5.77% | 5.53% | -21.37% |
Cost of Revenue | 55,349 | 55,709 | 53,057 | 50,147 | 47,422 |
Gross Profit | 8,800 | 8,777 | 8,498 | 8,048 | 7,723 |
Selling, General & Admin | 7,817 | 7,728 | 7,333 | 6,705 | 6,587 |
Amortization of Goodwill & Intangibles | 45 | 45 | 28 | 14 | 22 |
Operating Expenses | 8,012 | 7,902 | 7,476 | 6,892 | 6,793 |
Operating Income | 788 | 875 | 1,022 | 1,156 | 930 |
Interest Expense | -6 | -6 | - | -2 | -4 |
Interest & Investment Income | 15 | 12 | 10 | 9 | 10 |
Earnings From Equity Investments | - | -1 | -6 | -7 | 10 |
Currency Exchange Gain (Loss) | -10 | - | -4 | - | -1 |
Other Non Operating Income (Expenses) | 139 | 66 | 52 | 51 | 60 |
EBT Excluding Unusual Items | 926 | 946 | 1,074 | 1,207 | 1,005 |
Gain (Loss) on Sale of Investments | -2 | -3 | - | 33 | 4 |
Gain (Loss) on Sale of Assets | - | - | -4 | - | - |
Asset Writedown | -9 | - | -200 | - | - |
Other Unusual Items | 14 | - | - | -605 | 17 |
Pretax Income | 929 | 943 | 870 | 635 | 1,026 |
Income Tax Expense | 282 | 329 | 293 | 423 | 330 |
Earnings From Continuing Operations | 647 | 614 | 577 | 212 | 696 |
Minority Interest in Earnings | 1 | 2 | 3 | 7 | - |
Net Income | 648 | 616 | 580 | 219 | 696 |
Net Income to Common | 648 | 616 | 580 | 219 | 696 |
Net Income Growth | 5.20% | 6.21% | 164.84% | -68.53% | 2.66% |
Shares Outstanding (Basic) | 3 | 2 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 2 | 3 | 3 | 3 |
Shares Change | 1.52% | -3.01% | -0.28% | - | - |
EPS (Basic) | 258.49 | 249.47 | 227.83 | 85.79 | 272.63 |
EPS (Diluted) | 258.49 | 249.47 | 227.83 | 85.79 | 272.63 |
EPS Growth | 3.62% | 9.50% | 165.58% | -68.53% | 2.66% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Free Cash Flow | -1,203 | 338 | 804 | 2,121 | 474 |
Free Cash Flow Per Share | -479.88 | 136.88 | 315.81 | 830.82 | 185.67 |
Dividend Per Share | 77.000 | 75.000 | 70.000 | 48.000 | 82.000 |
Dividend Growth | 2.67% | 7.14% | 45.83% | -41.46% | 2.50% |
Gross Margin | 13.72% | 13.61% | 13.81% | 13.83% | 14.01% |
Operating Margin | 1.23% | 1.36% | 1.66% | 1.99% | 1.69% |
Profit Margin | 1.01% | 0.95% | 0.94% | 0.38% | 1.26% |
Free Cash Flow Margin | -1.88% | 0.52% | 1.31% | 3.65% | 0.86% |
EBITDA | 1,048 | 1,100 | 1,235 | 1,359 | 1,151 |
EBITDA Margin | 1.63% | 1.71% | 2.01% | 2.33% | 2.09% |
D&A For EBITDA | 260 | 225 | 213 | 203 | 221 |
EBIT | 788 | 875 | 1,022 | 1,156 | 930 |
EBIT Margin | 1.23% | 1.36% | 1.66% | 1.99% | 1.69% |
Effective Tax Rate | 30.35% | 34.89% | 33.68% | 66.61% | 32.16% |